Fig. 3From: Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathyDistributions of FEV1 scores and predictions for seven patients from the NHS (2- and 3-digit identification numbers) and five patients for who only a run-in period data are availableBack to article page